Detalhe da pesquisa
1.
Optimal sequencing of enzalutamide and abiraterone acetate plus prednisone in metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase 2, crossover trial.
Lancet Oncol
; 20(12): 1730-1739, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31727538
2.
Clinical effectiveness of docetaxel for castration-sensitive prostate cancer in a real-world population-based analysis.
Prostate
; 79(3): 281-287, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30370697
3.
Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.
J Pathol
; 246(2): 244-253, 2018 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-30015382
4.
Prediction of plasma ctDNA fraction and prognostic implications of liquid biopsy in advanced prostate cancer.
Nat Commun
; 15(1): 1828, 2024 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38418825
5.
Effectiveness of first-line abiraterone versus enzalutamide among patients ≥80 years of age with metastatic castration-resistant prostate cancer: A retrospective propensity score-weighted comparative cohort study.
Eur J Cancer
; 152: 215-222, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34130153
6.
Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.
Clin Cancer Res
; 27(16): 4610-4623, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34083234
7.
Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial.
Eur Urol
; 75(6): 940-947, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30591354
8.
Circulating Tumor DNA Genomics Correlate with Resistance to Abiraterone and Enzalutamide in Prostate Cancer.
Cancer Discov
; 8(4): 444-457, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29367197
9.
Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy.
Cancers (Basel)
; 9(2)2017 Jan 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28134800
10.
KHYG-1, a model for the study of enhanced natural killer cell cytotoxicity.
Exp Hematol
; 33(10): 1160-71, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16219538
11.
Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes.
Clin Colorectal Cancer
; 15(1): 16-23, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26281943
12.
Cost-effectiveness of therapies for melanoma.
Expert Rev Pharmacoecon Outcomes Res
; 15(2): 229-42, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25703441